AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, October 26 – 30, 2017

[vc_row][vc_column width=”1/1″][vc_column_text]Philadelphia, Pennsylvania, USA

OncoArendi will present a poster on the Development of OATD-02, a novel arginase 1 and 2 inhibitor for cancer immunotherapy. (Poster Session B, Sunday Oct 29, 2017 12:30 PM – 4:00 PM, Hall E)

[/vc_column_text][/vc_column][/vc_row]